Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 10Breast 3Lymphoid 2Thoracic 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1Dermatologic 1CNS 1

Conditions

Neuroendocrine Tumors 130Pituitary Neoplasms 72Thyroid Cancer, Papillary 59Pheochromocytoma 54Multiple Endocrine Neoplasia Type 1 31Thyroid Neoplasms 30Paraganglioma 28Adrenal Gland Neoplasms 27Neoplasms 26Pancreatic Neoplasms 21Carcinoid Tumor 20Adrenocortical Carcinoma 19Hyperaldosteronism 17Cushing Syndrome 17Carcinoma, Neuroendocrine 17Gastro-enteropancreatic neuroendocrine tumor 16Acromegaly 15Pituitary Diseases 14Lung Neoplasms 13Stomach Neoplasms 11Prostatic Neoplasms 11Neoplasm Metastasis 11Carcinoma, Hepatocellular 11Breast Neoplasms 11Multiple Endocrine Neoplasia 10Melanoma 10Thyroid Carcinoma, Anaplastic 9Prolactinoma 9Lymphatic Metastasis 9Insulinoma 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hypothyroidism × Endocrine × Clear all
NCT01441154 2020-09-28

Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment

National Institutes of Health Clinical Center (CC)

Completed
16 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Hypothyroidism, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡